WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

New light on how a mutation in a protein causes acute myeloid leukaemia

Details
Research
09 April 2008
An international team of scientists has shed new light on how a mutation in a protein causes acute myeloid leukaemia (AML), a type of blood cancer. The findings have implications for our understanding of AML, and the way leukaemias are treated. The work, which is partly funded by the EU, is published in the latest edition of the journal Cancer Cell.
Read more ...

Man-made chemicals which mimic oestrogen contribute to breast cancer

Details
Research
04 April 2008
Health campaigners are urging politicians to act on the growing body of scientific evidence that links exposure to certain chemicals to spiralling rates of breast cancer. Scientists have known for decades that a woman's risk of developing breast cancer is influenced both by the levels of oestrogen produced by her own body and her use of drugs containing man-made oestrogens, such as hormone replacement therapy (HRT).
Read more ...

Protein discovery sheds light on autoimmune diseases

Details
Research
03 April 2008
The immune system is made up of a collection of mechanisms that protect our bodies from disease and infection. But if you have an autoimmune disease, your own immune system attacks itself by mistake. Many parts of the body can be affected by these diseases, including nerves, muscles, and the endocrine and digestive systems.
Read more ...

Ascribe Extends Integrated Pharmacy and Robotic IT Systems to Royal Bolton Hospital

Details
Research
02 April 2008
Ascribe plc (AIM:ASP), the innovative health IT Group, today announced that it has successfully installed its Web Pharmacy solution at the Royal Bolton Hospital, part of the Bolton Hospitals NHS Trust and that the site is completely operational. One unique aspect of this 'Go Live' was that, on the same day that the hospital changed its pharmacy IT system, they also brought online a robotic dispensing system; thereby taking a massive leap forward in improving patient care and safety.
Read more ...

Female sex hormone helps protect against hearing loss

Details
Research
31 March 2008
Our hearing is one of the wonders of the human body which is all too often taken for granted. Like many things in life, we don't really appreciate our ability to hear clearly until we begin to lose it. As we age, our ability to discern sounds begins to deteriorate. Therefore, new innovative therapies to guard the hearing of patients are eagerly sought after.
Read more ...

The Drug Check eTEN Project to validate an on-line pan-European service

Details
Research
28 March 2008
The objective of the Drug Check project is to validate an on-line, pan-European service, which gathers, organises, stores, makes available and presents information and data covering pharmaceuticals and their interactions.
Read more ...

Ozmosis - Trusted Environment for Physicians

Details
Research
28 March 2008
Physicians now have a "trusted environment" where they learn the way they learn best - from each other - with launch of Ozmosis, a verified, physicians-only online information exchange dedicated to the discovery and sharing of medical knowledge and the improvement of patient care.
Read more ...

More Pharma News ...

  1. Doctors & Dentists Urged To Learn On The Net
  2. New EU project to focus on membrane proteins with the aim of finding new treatments
  3. Integrating sex and gender differences in health research
  4. Public consultation in preparation of a legal proposal to combat counterfeit medicines for human use
  5. FDA Takes Next Step in Establishing Overseas Presence
  6. ALERT project looks to ICT for drug safety
  7. Tattooing is a more effective way of administering DNA vaccines than direct injection
  • Start
  • Prev
  • 285
  • 286
  • 287
  • 288
  • 289
  • 290
  • 291
  • 292
  • 293
  • 294
  • Next
  • End

Business & Industry

  • GSK completes acquisition of Sierra Oncology
  • Pfizer and BioNTech announce new agreement with U.S. government to provide additional doses of COVID-19 vaccine
  • Bayer opens new Research & Innovation Center in Boston-Cambridge demonstrating its commitment to precision oncology
  • New Novartis extension phase data show nearly 80% of RMS patients treated with Kesimpta® (ofatumumab) had no evidence of disease activity (NEDA-3)
  • Pfizer and BioNTech announce Omicron-adapted COVID-19 vaccine candidates demonstrate high immune response against Omicron

Research & Development

  • Researchers discover new leukemia-killing compounds
  • Oral antiviral drug effective against respiratory syncytial virus (RSV) identified by researchers
  • Biomarkers found that could be drug targets against a deadly form of brain cancer
  • COVID-19 rebound after taking Paxlovid likely due to insufficient drug exposure
  • Novel drug combo activates natural killer cell immunity to destroy cancer cells
  • Broadly neutralizing antibodies could provide immunity against SARS-CoV-2 variants
  • A new technology offers treatment for HIV infection through a single injection

Conferences & Events

  • New approach to treatment of deadly kidney cancer
  • SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
  • Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
  • SMi's 22nd Annual Pain Therapeutics Conference
  • SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
  • SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
  • SMi's 3rd Annual AI in Drug Discovery Conference

Regulatory Affairs

  • FDA approves first systemic treatment for alopecia areata
  • FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
  • FDA limits use of Janssen COVID-19 vaccine to certain individuals
  • EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
  • FDA approves first generic of Symbicort to treat asthma and COPD
  1. You are here:  
  2. Home
  3. Research
  4. Researchers discover new leukemia-killing compounds

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2022. All Rights Reserved.